Oral weight-loss drugs have been hailed as a medical breakthrough, promising powerful results without injections. But new Australian research suggests a key ingredient in these pills may cause unintended biological consequences.
The study from Adelaide University, published in the Journal of Controlled Release, found a key ingredient in oral weight-loss drugs, salcaprozate sodium (SNAC), could cause biological changes in the gut microbiome and metabolism.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
